28% have talked with a doctor about a drug they saw advertised

UnknownKEY SUMMARY: A large majority of Americans (82 percent) report seeing or hearing prescription drug advertisements, and 3 in 10 (28 percent) say they have talked with a doctor about the specific medicine they saw advertised. After talking to a doctor about a drug they saw, 15 percent of the public says the doctor recommended changes in their behavior or lifestyle, 14 percent say the doctor recommended a different prescription drug, 12 percent say they were given the drug they asked about, and 11 percent were instead recommended an over-the-counter option. Source: Kaiser Health Tracking Poll Continue reading

Statistics on mobile health mean little

Unknown-1“Nobody has figured out how to make consumers — patients — care about mobile health technologies. “And if we don’t [figure that out], m-health will be another tech bubble”. Dr. Joseph Kvedar, director of the Center for Connected Health. Continue reading

What patients want from healthcare

UnknownPOST SUMMARY: I spent a lot of time this year leading qualitative research along with analyzing quantitative research.  I keep all the research report findings in a binder and while it’s true that a lot of the insights can’t be applied across all health conditions there are some common needs/wants.  Here are some of the most common..

Continue reading

Friday summary of news for pharma

fridaynewsMore Americans surviving cancer than ever. The number of cancer survivors in the U.S. will grow to almost 19 million in 2024, according to a new report from the American Cancer Society. The report says there are currently 14.5 million cancer survivors living in the country. Continue reading

H2H Marketing in Biopharma: A Utopian ideal, naïveté or the inevitable and needed conclusion.

screenshot_03Summary: Guest blogger Alfred O’Neill discusses the emerging mass market marketing philosophy called H2H – Human2Human – and how it is best applied in Biopharma industry. He also offers some examples and recommendations on how companies can master this new approach. Continue reading